miR-223-3p mediates the diabetic kidney disease progression by targeting IL6ST/STAT3 pathway. Tang P, Xu Y, Zhang J, Nan J, et al. Biochem Biophys Res Commun 2023;648:50-58.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tang P, Xu Y, Zhang J, Nan J, et al. miR-223-3p mediates the diabetic kidney disease progression by targeting IL6ST/STAT3 pathway. Biochem Biophys Res Commun 2023;648:50-58.
PMID: 36731227